Mindpeak's AI Comes out on Top in Comparative Study on HER2-

In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy

Related Keywords

Canada , United States , Canadian , Carsten Maltzan , Institut Gustave Roussy , Astrazeneca , Canadian Academy Of Pathology , Canadian Academy , New Orleans , Mindpeak Breast , Business Wire , Mindpeak , Homes , Comparative , Study , Ther2 , Scoring , Mypath , Institut , Gustave , Moussy ,